Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2(-) breast cancer that had progressed during or...

Musolino Antonino, Campone Mario, Neven Patrick, Denduluri Neelima, Barrios Carlos H, Cortes Javier, Blackwell Kimberly, Soliman Hatem, Kahán Zsuzsanna, Bonnefoi Herve, Squires Matthew, Zhang Yong, Deudon Stephanie, Shi Michael M, Andre Fabrice
2017